297 related articles for article (PubMed ID: 24812137)
1. Prostate cancer, version 2.2014.
Mohler JL; Kantoff PW; Armstrong AJ; Bahnson RR; Cohen M; D'Amico AV; Eastham JA; Enke CA; Farrington TA; Higano CS; Horwitz EM; Kane CJ; Kawachi MH; Kuettel M; Kuzel TM; Lee RJ; Malcolm AW; Miller D; Plimack ER; Pow-Sang JM; Raben D; Richey S; Roach M; Rohren E; Rosenfeld S; Schaeffer E; Small EJ; Sonpavde G; Srinivas S; Stein C; Strope SA; Tward J; Shead DA; Ho M;
J Natl Compr Canc Netw; 2014 May; 12(5):686-718. PubMed ID: 24812137
[TBL] [Abstract][Full Text] [Related]
2. NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
Schaeffer EM; Srinivas S; Adra N; An Y; Barocas D; Bitting R; Bryce A; Chapin B; Cheng HH; D'Amico AV; Desai N; Dorff T; Eastham JA; Farrington TA; Gao X; Gupta S; Guzzo T; Ippolito JE; Kuettel MR; Lang JM; Lotan T; McKay RR; Morgan T; Netto G; Pow-Sang JM; Reiter R; Roach M; Robin T; Rosenfeld S; Shabsigh A; Spratt D; Teply BA; Tward J; Valicenti R; Wong JK; Berardi RA; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2022 Dec; 20(12):1288-1298. PubMed ID: 36509074
[TBL] [Abstract][Full Text] [Related]
3. Current clinical presentation and treatment of localized prostate cancer in the United States.
Mahmood U; Levy LB; Nguyen PL; Lee AK; Kuban DA; Hoffman KE
J Urol; 2014 Dec; 192(6):1650-6. PubMed ID: 24931803
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.
Mohler JL; Armstrong AJ; Bahnson RR; Boston B; Busby JE; D'Amico AV; Eastham JA; Enke CA; Farrington T; Higano CS; Horwitz EM; Kantoff PW; Kawachi MH; Kuettel M; Lee RJ; MacVicar GR; Malcolm AW; Miller D; Plimack ER; Pow-Sang JM; Roach M; Rohren E; Rosenfeld S; Srinivas S; Strope SA; Tward J; Twardowski P; Walsh PC; Ho M; Shead DA
J Natl Compr Canc Netw; 2012 Sep; 10(9):1081-7. PubMed ID: 22956807
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.
Carroll PR; Parsons JK; Andriole G; Bahnson RR; Barocas DA; Catalona WJ; Dahl DM; Davis JW; Epstein JI; Etzioni RB; Giri VN; Hemstreet GP; Kawachi MH; Lange PH; Loughlin KR; Lowrance W; Maroni P; Mohler J; Morgan TM; Nadler RB; Poch M; Scales C; Shanefelt TM; Vickers AJ; Wake R; Shead DA; Ho M;
J Natl Compr Canc Netw; 2014 Sep; 12(9):1211-9; quiz 1219. PubMed ID: 25190691
[TBL] [Abstract][Full Text] [Related]
6. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021.
Schaeffer E; Srinivas S; Antonarakis ES; Armstrong AJ; Bekelman JE; Cheng H; D'Amico AV; Davis BJ; Desai N; Dorff T; Eastham JA; Farrington TA; Gao X; Horwitz EM; Ippolito JE; Kuettel MR; Lang JM; McKay R; McKenney J; Netto G; Penson DF; Pow-Sang JM; Reiter R; Richey S; Roach Iii M; Rosenfeld S; Shabsigh A; Spratt DE; Teply BA; Tward J; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2021 Feb; 19(2):134-143. PubMed ID: 33545689
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer, version 1.2014.
Mohler JL; Kantoff PW; Armstrong AJ; Bahnson RR; Cohen M; D'Amico AV; Eastham JA; Enke CA; Farrington TA; Higano CS; Horwitz EM; Kawachi MH; Kuettel M; Lee RJ; Macvicar GR; Malcolm AW; Miller D; Plimack ER; Pow-Sang JM; Richey S; Roach M; Rohren E; Rosenfeld S; Small EJ; Srinivas S; Stein C; Strope SA; Tward J; Walsh PC; Shead DA; Ho M;
J Natl Compr Canc Netw; 2013 Dec; 11(12):1471-9. PubMed ID: 24335682
[TBL] [Abstract][Full Text] [Related]
8. Impact of an NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer.
Hussein AA; Iqbal U; Jing Z; Ramahi Y; Houenstein H; Newman S; Peterson B; Krajacic K; Samoni A; Xu B; Sule N; Azabdaftari G; Kauffman EC; Mohler JL; Kuettel M; Guru KA
J Natl Compr Canc Netw; 2023 Apr; 21(4):359-365.e4. PubMed ID: 37015336
[TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
Mohler JL; Antonarakis ES; Armstrong AJ; D'Amico AV; Davis BJ; Dorff T; Eastham JA; Enke CA; Farrington TA; Higano CS; Horwitz EM; Hurwitz M; Ippolito JE; Kane CJ; Kuettel MR; Lang JM; McKenney J; Netto G; Penson DF; Plimack ER; Pow-Sang JM; Pugh TJ; Richey S; Roach M; Rosenfeld S; Schaeffer E; Shabsigh A; Small EJ; Spratt DE; Srinivas S; Tward J; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2019 May; 17(5):479-505. PubMed ID: 31085757
[TBL] [Abstract][Full Text] [Related]
10. NCCN Guidelines Updates: Management of Prostate Cancer.
Mohler JL; Antonarakis ES
J Natl Compr Canc Netw; 2019 May; 17(5.5):583-586. PubMed ID: 31117038
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.
Tempero MA; Arnoletti JP; Behrman SW; Ben-Josef E; Benson AB; Casper ES; Cohen SJ; Czito B; Ellenhorn JD; Hawkins WG; Herman J; Hoffman JP; Ko A; Komanduri S; Koong A; Ma WW; Malafa MP; Merchant NB; Mulvihill SJ; Muscarella P; Nakakura EK; Obando J; Pitman MB; Sasson AR; Tally A; Thayer SP; Whiting S; Wolff RA; Wolpin BM; Freedman-Cass DA; Shead DA;
J Natl Compr Canc Netw; 2012 Jun; 10(6):703-13. PubMed ID: 22679115
[TBL] [Abstract][Full Text] [Related]
12. Prostate Cancer, Version 1.2016.
Mohler JL; Armstrong AJ; Bahnson RR; D'Amico AV; Davis BJ; Eastham JA; Enke CA; Farrington TA; Higano CS; Horwitz EM; Hurwitz M; Kane CJ; Kawachi MH; Kuettel M; Lee RJ; Meeks JJ; Penson DF; Plimack ER; Pow-Sang JM; Raben D; Richey S; Roach M; Rosenfeld S; Schaeffer E; Skolarus TA; Small EJ; Sonpavde G; Srinivas S; Strope SA; Tward J; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2016 Jan; 14(1):19-30. PubMed ID: 26733552
[TBL] [Abstract][Full Text] [Related]
13. Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa region.
Hassen WA; Karsan FA; Abbas F; Beduk Y; El-Khodary A; Ghosn M; Khader J; Khauli R; Rabah DM; Shamseddine A; Srinivas S;
J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S26-8. PubMed ID: 20697128
[TBL] [Abstract][Full Text] [Related]
14. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.
Moses KA; Sprenkle PC; Bahler C; Box G; Carlsson SV; Catalona WJ; Dahl DM; Dall'Era M; Davis JW; Drake BF; Epstein JI; Etzioni RB; Farrington TA; Garraway IP; Jarrard D; Kauffman E; Kaye D; Kibel AS; LaGrange CA; Maroni P; Ponsky L; Reys B; Salami SS; Sanchez A; Seibert TM; Shaneyfelt TM; Smaldone MC; Sonn G; Tyson MD; Vapiwala N; Wake R; Washington S; Yu A; Yuh B; Berardi RA; Freedman-Cass DA
J Natl Compr Canc Netw; 2023 Mar; 21(3):236-246. PubMed ID: 36898362
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.
Aizer AA; Paly JJ; Zietman AL; Nguyen PL; Beard CJ; Rao SK; Kaplan ID; Niemierko A; Hirsch MS; Wu CL; Olumi AF; Michaelson MD; D'Amico AV; Efstathiou JA
J Clin Oncol; 2012 Sep; 30(25):3071-6. PubMed ID: 22851571
[TBL] [Abstract][Full Text] [Related]
16. Prostate Cancer, Version 3.2024.
Schaeffer EM; Srinivas S; Adra N; An Y; Bitting R; Chapin B; Cheng HH; D'Amico AV; Desai N; Dorff T; Eastham JA; Farrington TA; Gao X; Gupta S; Guzzo T; Ippolito JE; Karnes RJ; Kuettel MR; Lang JM; Lotan T; McKay RR; Morgan T; Pow-Sang JM; Reiter R; Roach M; Robin T; Rosenfeld S; Shabsigh A; Spratt D; Szmulewitz R; Teply BA; Tward J; Valicenti R; Wong JK; Snedeker J; Freedman-Cass DA
J Natl Compr Canc Netw; 2024 Apr; 22(3):140-150. PubMed ID: 38626801
[TBL] [Abstract][Full Text] [Related]
17. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
Barocas DA; Cowan JE; Smith JA; Carroll PR;
J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
[TBL] [Abstract][Full Text] [Related]
18. NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
Carroll PR; Parsons JK; Andriole G; Bahnson RR; Castle EP; Catalona WJ; Dahl DM; Davis JW; Epstein JI; Etzioni RB; Farrington T; Hemstreet GP; Kawachi MH; Kim S; Lange PH; Loughlin KR; Lowrance W; Maroni P; Mohler J; Morgan TM; Moses KA; Nadler RB; Poch M; Scales C; Shaneyfelt TM; Smaldone MC; Sonn G; Sprenkle P; Vickers AJ; Wake R; Shead DA; Freedman-Cass DA
J Natl Compr Canc Netw; 2016 May; 14(5):509-19. PubMed ID: 27160230
[TBL] [Abstract][Full Text] [Related]
19. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Jan; 65(1):124-37. PubMed ID: 24207135
[TBL] [Abstract][Full Text] [Related]
20. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
